Michael W.Y. Chan

3.2k total citations
92 papers, 2.0k citations indexed

About

Michael W.Y. Chan is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Michael W.Y. Chan has authored 92 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Molecular Biology, 21 papers in Cancer Research and 16 papers in Surgery. Recurrent topics in Michael W.Y. Chan's work include Epigenetics and DNA Methylation (33 papers), Cancer-related gene regulation (17 papers) and RNA modifications and cancer (15 papers). Michael W.Y. Chan is often cited by papers focused on Epigenetics and DNA Methylation (33 papers), Cancer-related gene regulation (17 papers) and RNA modifications and cancer (15 papers). Michael W.Y. Chan collaborates with scholars based in Taiwan, United States and Canada. Michael W.Y. Chan's co-authors include Kenneth P. Nephew, Pearlly S. Yan, Alfred S.L. Cheng, Ka‐Fai To, Tim H-M. Huang, Hung‐Cheng Lai, Rui Huang, Sandya Liyanarachchi, Juan Chen and Ramana V. Davuluri and has published in prestigious journals such as Journal of the American Chemical Society, Molecular Cell and Gastroenterology.

In The Last Decade

Michael W.Y. Chan

86 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael W.Y. Chan Taiwan 27 1.2k 408 282 271 270 92 2.0k
Rakesh Sharma India 24 978 0.8× 422 1.0× 287 1.0× 243 0.9× 206 0.8× 78 2.0k
Ying Ni United States 25 1.2k 1.0× 434 1.1× 305 1.1× 165 0.6× 209 0.8× 114 2.1k
Juna Lee United States 24 1.6k 1.3× 311 0.8× 287 1.0× 410 1.5× 299 1.1× 44 2.1k
Yinglu Guo China 27 1.1k 0.9× 419 1.0× 361 1.3× 368 1.4× 210 0.8× 75 2.2k
Francesca Ricci Italy 28 856 0.7× 350 0.9× 627 2.2× 365 1.3× 198 0.7× 98 2.1k
Changzheng Wang China 19 1.1k 0.9× 776 1.9× 260 0.9× 169 0.6× 176 0.7× 35 1.8k
Gerold Untergasser Austria 29 1.1k 1.0× 370 0.9× 527 1.9× 411 1.5× 191 0.7× 84 2.4k
Li Min China 25 1.2k 1.1× 685 1.7× 332 1.2× 264 1.0× 231 0.9× 96 1.9k
Jianxiang Chen China 27 1.1k 0.9× 481 1.2× 306 1.1× 333 1.2× 130 0.5× 111 2.2k
Jianzhong Ai China 23 762 0.7× 285 0.7× 416 1.5× 376 1.4× 291 1.1× 125 1.9k

Countries citing papers authored by Michael W.Y. Chan

Since Specialization
Citations

This map shows the geographic impact of Michael W.Y. Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael W.Y. Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael W.Y. Chan more than expected).

Fields of papers citing papers by Michael W.Y. Chan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael W.Y. Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael W.Y. Chan. The network helps show where Michael W.Y. Chan may publish in the future.

Co-authorship network of co-authors of Michael W.Y. Chan

This figure shows the co-authorship network connecting the top 25 collaborators of Michael W.Y. Chan. A scholar is included among the top collaborators of Michael W.Y. Chan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael W.Y. Chan. Michael W.Y. Chan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Yan, Wen‐Bin Yeh, Renin Chang, et al.. (2025). A novel σB regulatory module in staphylococcus aureus: Unraveling the multifaceted roles of RsbU domains in stress response mechanisms. Journal of Microbiology Immunology and Infection. 58(6). 652–662.
2.
Jiang, Yuan‐Hong, Jia‐Fong Jhang, Hann‐Chorng Kuo, et al.. (2024). Hypermethylation Loci of ZNF671, IRF8, and OTX1 as Potential Urine-Based Predictive Biomarkers for Bladder Cancer. Diagnostics. 14(5). 468–468. 8 indexed citations
3.
Lin, Hon‐Yi, Chen-Hsi Hsieh, Michael W.Y. Chan, et al.. (2023). IRAK2, an Immune and Radiation-Response Gene, Correlates with Advanced Disease Features but Predicts Higher Post-Irradiation Local Control in Non-Metastatic and Resected Oral Cancer Patients. International Journal of Molecular Sciences. 24(8). 6903–6903. 3 indexed citations
4.
Furuya, Hideki, Steve Goodison, Ian Pagano, et al.. (2023). Association of SNPs in the PAI1 Gene with Disease Recurrence and Clinical Outcome in Bladder Cancer. International Journal of Molecular Sciences. 24(5). 4943–4943. 4 indexed citations
5.
Lee, Yu‐Ting, Chi‐Wen Tu, Ming‐Yang Lee, et al.. (2022). Parathyroidectomy Improves the Consumption of Erythropoiesis-Stimulating Agents in Hemodialysis Patients. International Journal of Molecular Sciences. 23(18). 10391–10391. 1 indexed citations
6.
Chuang, Yu‐Ming, et al.. (2022). Interplay between ceRNA and Epigenetic Control of microRNA: Modelling Approaches with Application to the Role of Estrogen in Ovarian Cancer. International Journal of Molecular Sciences. 23(4). 2277–2277. 5 indexed citations
7.
Lee, Ying‐Ray, et al.. (2022). RNA Interference Approach Is a Good Strategy against SARS-CoV-2. Viruses. 15(1). 100–100. 6 indexed citations
8.
Yeh, Kun‐Tu, Yu‐Ming Chuang, Yu‐Ting Lee, et al.. (2021). Methylomic analysis identifies C11orf87 as a novel epigenetic biomarker for GI cancers. PLoS ONE. 16(4). e0250499–e0250499. 4 indexed citations
9.
Jou, Yeong‐Chin, Hon‐Yi Lin, Yu‐Ming Chuang, et al.. (2021). Cyproheptadine, an epigenetic modifier, exhibits anti-tumor activity by reversing the epigenetic silencing of IRF6 in urothelial carcinoma. Cancer Cell International. 21(1). 226–226. 5 indexed citations
10.
Kang, Wei, Jinglin Zhang, Tingting Huang, et al.. (2021). NOTCH3, a crucial target of miR-491-5p/miR-875-5p, promotes gastric carcinogenesis by upregulating PHLDB2 expression and activating Akt pathway. Oncogene. 40(9). 1578–1594. 26 indexed citations
11.
Hussain, Bashir, Jung‐Sheng Chen, Bing‐Mu Hsu, et al.. (2021). Deciphering Bacterial Community Structure, Functional Prediction and Food Safety Assessment in Fermented Fruits Using Next-Generation 16S rRNA Amplicon Sequencing. Microorganisms. 9(8). 1574–1574. 23 indexed citations
12.
Lee, Yu‐Ting, Yu‐Ming Chuang, & Michael W.Y. Chan. (2020). Combinatorial Epigenetic and Immunotherapy in Breast Cancer Management: A Literature Review. Epigenomes. 4(4). 27–27. 7 indexed citations
13.
Chang, Te‐Sheng, Chung‐Kuang Lu, Yung‐Yu Hsieh, et al.. (2020). 2,4-Diamino-Quinazoline, a Wnt Signaling Inhibitor, Suppresses Gastric Cancer Progression and Metastasis. International Journal of Molecular Sciences. 21(16). 5901–5901. 12 indexed citations
14.
Wei, Kuo‐Liang, et al.. (2019). Methylomics analysis identifies a putative STAT3 target, SPG20, as a noninvasive epigenetic biomarker for early detection of gastric cancer. PLoS ONE. 14(6). e0218338–e0218338. 13 indexed citations
15.
Shinjo, Keiko, Keisuke Katsushima, Atsushi Arakawa, et al.. (2019). ZNF671 DNA methylation as a molecular predictor for the early recurrence of serous ovarian cancer. Cancer Science. 110(3). 1105–1116. 30 indexed citations
16.
Chuang, Yu‐Ming, Ru‐Inn Lin, Hon‐Yi Lin, et al.. (2019). c-Myc Acts as a Competing Endogenous RNA to Sponge miR-34a, in the Upregulation of CD44, in Urothelial Carcinoma. Cancers. 11(10). 1457–1457. 14 indexed citations
17.
Huang, Rui, Phui‐Ly Liew, Po‐Hsuan Su, et al.. (2018). GATA3 as a master regulator and therapeutic target in ovarian high‐grade serous carcinoma stem cells. International Journal of Cancer. 143(12). 3106–3119. 32 indexed citations
18.
Wu, Cheng-Shyong, Kuo‐Liang Wei, Jian‐Liang Chou, et al.. (2016). Aberrant JAK/STAT Signaling Suppresses TFF1 and TFF2 through Epigenetic Silencing of GATA6 in Gastric Cancer. International Journal of Molecular Sciences. 17(9). 1467–1467. 27 indexed citations
19.
Huang, Pei‐Yu, et al.. (2014). FT-IR Microspectrometry Reveals the Variation of Membrane Polarizability due to Epigenomic Effect on Epithelial Ovarian Cancer. International Journal of Molecular Sciences. 15(10). 17963–17973. 11 indexed citations
20.
Cheng, Alfred S.L., Aedín C. Culhane, Michael W.Y. Chan, et al.. (2008). Epithelial Progeny of Estrogen-Exposed Breast Progenitor Cells Display a Cancer-like Methylome. Cancer Research. 68(6). 1786–1796. 112 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026